NCT02712905 2025-11-04An Open-Label, Dose-Escalation/Dose-Expansion Safety Study of INCB059872 in Subjects With Advanced MalignanciesIncyte CorporationPhase 1/2 Terminated116 enrolled 36 charts
NCT02711137 2025-10-21Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced MalignanciesIncyte CorporationPhase 1/2 Terminated137 enrolled 31 charts
NCT01290302 2025-06-12Blinded Cross-Over Bioequivalence (BE) Trial of Luitpold Azacitidine vs VidazaAmerican Regent, Inc.Phase 1 Completed38 enrolled 14 charts
NCT02587598 2021-12-08Study of INCB053914 in Subjects With Advanced MalignanciesIncyte CorporationPhase 1/2 Terminated97 enrolled 40 charts
NCT00569660 2012-08-07Ph II Study of Azacitidine in MyelofibrosisM.D. Anderson Cancer CenterPhase 2 Completed34 enrolled 6 charts
NCT00381693 2011-04-21Azacitidine in Treating Patients With MyelofibrosisMayo ClinicPhase 2 Terminated10 enrolled 11 charts